Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
Get Your Finances in Order With CBIZ
President and CEO of CBIZ Jerry Grisko breaks down the financial services company’s latest earnings results.
The Audio A.I. Company That Received a Nvidia Investment
Soundhound AI co-founder, president, and CEO Keyvan Mojaver discusses bringing its audio tools to cars and drive-thrus, plus why smaller companies may benefit from the A.I. boom.
‘Almost Every Company’ Is Planning to Use A.I.
Deiya Pernas, co-founder of Pernas Research, breaks down Nvidia’s blockbuster earnings, why energy is a sector to watch, and why the A.I. trend is far from over.
Who Will Air Basketball Games? The NBA Is Playing the Field
The NBA is organizing its next media rights deal to figure out which networks and streaming services will show their games for the next decade. Last time, most of the prominent streaming services didn't exist yet.
2 Things Pet Insurance Will Cover (And 3 It Won’t)
When times get ruff for your fur babies, are you paws-itive that pet insurance is right for you?
The Biggest Trends in VC Investments
Founding partner of the Female Founders Fund Anu Duggal shares the latest developments in the world of venture capital.
Car Expenses Are Rising – Here’s How to Save
Lauren Fix of Car Coach Report breaks down the increasing cost of car ownership – and what consumers can do to keep their personal expenditures lower.
Using Tech to Make Spinal Taps Safer for Millions of Americans
Jessica Traver Ingram, CEO and co-founder of IntuiTap Medical, discusses developing the company's Ver Touch device, the crucial FDA approval it just won, and why innovation in spinal blocks and epidurals is long overdue.
What's to Come for the 'Magnificent 7'
Matt Stucky, Chief Portfolio Manager of Equities at Northwestern Mutual Wealth Management chats why Nvidia has been unsteady leading up to its latest earnings results, plus what’s to come for the so-called ‘Magnificent 7.’
